Edition:
United States

Glaukos Corp (GKOS.N)

GKOS.N on New York Stock Exchange

31.23USD
20 Feb 2018
Change (% chg)

$0.16 (+0.51%)
Prev Close
$31.07
Open
$31.01
Day's High
$31.69
Day's Low
$31.01
Volume
92,923
Avg. Vol
125,941
52-wk High
$52.41
52-wk Low
$23.10

Select another date:

Wed, Jan 10 2018

BRIEF-Glaukos' Idose Travoprost Achieves Sustained IOP Reduction And Favorable Safety Profile In 12-Month Interim Cohort

* GLAUKOS CORPORATION’S IDOSE™ TRAVOPROST ACHIEVES SUSTAINED IOP REDUCTION AND FAVORABLE SAFETY PROFILE IN 12-MONTH INTERIM COHORT

BRIEF-Glaukos Submits IDE Application To FDA To Study iStent Infinite Trabecular Micro-Bypass System

* GLAUKOS SUBMITS IDE APPLICATION TO FDA TO STUDY ISTENT INFINITE™ TRABECULAR MICRO-BYPASS SYSTEM

BRIEF-Glaukos Corp posts Q3 earnings per share $0.04

* Glaukos Corporation announces third quarter 2017 financial results

BRIEF-James Flynn reports a 7.34 pct passive stake in Glaukos

* James E. Flynn reports a 7.34 Pct passive stake in Glaukos Corp as of Sept 14 - SEC filing Source text: [http://bit.ly/2xBLsij] Further company coverage:

Select another date: